1. Home
  2. MSBI vs SLDB Comparison

MSBI vs SLDB Comparison

Compare MSBI & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSBI
  • SLDB
  • Stock Information
  • Founded
  • MSBI 1881
  • SLDB 2013
  • Country
  • MSBI United States
  • SLDB United States
  • Employees
  • MSBI N/A
  • SLDB N/A
  • Industry
  • MSBI Major Banks
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MSBI Finance
  • SLDB Health Care
  • Exchange
  • MSBI Nasdaq
  • SLDB Nasdaq
  • Market Cap
  • MSBI 437.3M
  • SLDB 234.8M
  • IPO Year
  • MSBI 2016
  • SLDB 2018
  • Fundamental
  • Price
  • MSBI $18.26
  • SLDB $2.77
  • Analyst Decision
  • MSBI Hold
  • SLDB Strong Buy
  • Analyst Count
  • MSBI 3
  • SLDB 9
  • Target Price
  • MSBI $21.33
  • SLDB $15.67
  • AVG Volume (30 Days)
  • MSBI 131.1K
  • SLDB 1.5M
  • Earning Date
  • MSBI 05-13-2025
  • SLDB 05-19-2025
  • Dividend Yield
  • MSBI 6.79%
  • SLDB N/A
  • EPS Growth
  • MSBI N/A
  • SLDB N/A
  • EPS
  • MSBI N/A
  • SLDB N/A
  • Revenue
  • MSBI $174,721,000.00
  • SLDB N/A
  • Revenue This Year
  • MSBI $77.95
  • SLDB N/A
  • Revenue Next Year
  • MSBI $3.09
  • SLDB $569.02
  • P/E Ratio
  • MSBI N/A
  • SLDB N/A
  • Revenue Growth
  • MSBI N/A
  • SLDB N/A
  • 52 Week Low
  • MSBI $14.79
  • SLDB $2.45
  • 52 Week High
  • MSBI $28.08
  • SLDB $10.99
  • Technical
  • Relative Strength Index (RSI)
  • MSBI 63.26
  • SLDB 41.62
  • Support Level
  • MSBI $17.56
  • SLDB $3.01
  • Resistance Level
  • MSBI $18.42
  • SLDB $4.35
  • Average True Range (ATR)
  • MSBI 0.52
  • SLDB 0.47
  • MACD
  • MSBI 0.28
  • SLDB 0.01
  • Stochastic Oscillator
  • MSBI 94.51
  • SLDB 14.18

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment which generates the majority of the revenue, provides a wide range of financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage and other consumer loan products; commercial equipment financing etc. The Wealth Management segment consists of trust and fiduciary services, brokerage and retirement planning services. The Other segment includes the operating results of the parent company.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: